IR-Med Inc. (IRME)
OTCMKTS · Delayed Price · Currency is USD
0.0250
0.00 (0.00%)
At close: Oct 9, 2025
IR-Med Market Cap
IR-Med has a market cap or net worth of $1.97 million as of October 13, 2025. Its market cap has decreased by -94.27% in one year.
Market Cap
1.97M
Enterprise Value
2.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since May 18, 2009, IR-Med's market cap has decreased from 6.41M to 1.97M, a decrease of -69.27%. That is a compound annual growth rate of -6.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 1.97M | -94.07% |
Dec 31, 2024 | 33.20M | -58.72% |
Dec 22, 2023 | 80.42M | 133.75% |
Dec 30, 2022 | 34.40M | -75.79% |
Dec 29, 2021 | 142.12M | 76,823.79% |
Dec 31, 2020 | 184.76K | -96.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elite Pharmaceuticals | 671.65M |
Glass House Brands | 650.22M |
Veradigm | 525.44M |
Northwest Biotherapeutics | 378.75M |
CytoDyn | 335.98M |
Nika Pharmaceuticals | 333.67M |
American Oncology Network | 283.44M |
Silence Therapeutics | 236.17M |